Top News  Safety Issues Public Policy AHRP Letter to FDA Commissioner-Themirosal
|
|
AHRP Letter to FDA Commissioner-Themirosal |
|
|
|
Wednesday, 08 March 2006 |
Our questions Re: Thimerosal are threefold.
ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP)
Promoting Openness, Full Disclosure, and Accountability
http://www.ahrp.org/cms/
March 8, 2006
Dr. Andrew vonEschenbach
FDA Commissioner
Dear Dr. vonEschenbach:
A study by Geier and Geier published in the March 1, 2006 issue of the Journal of American Physicians and Surgeons documents a decrease in neurodevelopmental disorders in children following removal of thimerosal from American childhood vaccines.
See: http://www.a-champ.org/documents/geier%20Early%20Downward%20Trends%20JAPS%203-1-06.pdf
The Alliance for Human Research Protection (AHRP) is requesting information about whether any childhood vaccines still remain available for use in the United States. Our concern relates to the published charge of Robert Kennedy, Jr., that "the government continues to ship vaccines preserved with thimerosal to developing countries -- some of which are now experiencing a sudden explosion in autism rates."
See: http://www.rollingstone.com/politics/story/7395411/deadly_immunity/?rnd=1141683124358&has-player=true&version=6.0.12.1040
Our questions are three-fold.
1. Has the FDA issued an official recall of the stock of vaccines containing thimerosal as a preservative for use in the United States?
2. If so, does the FDA have a list of vaccine lot numbers to which pediatricians and general medical practitioners can refer to check their current supply of vaccines on hand?
3. Is there any truth to the Kennedy claim that our government is shipping vaccines preserved with thimerosal to developing countries?
Thank you for your kind and expeditious response.
Sincerely,
Vera Hassner Sharav
President, Alliance for Human Research Protection
http:// www.ahrp.org/cms
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
|
|
